Luc Lanthier , Geneviève Le Templier , Alexandre Mutchmore , Marc-Émile Plourde , Michel Cauchon
{"title":"对于已经抗凝治疗至少6个月的活动性癌症和静脉血栓栓塞患者,与全剂量阿哌沙班相比,减少阿哌沙班的延长治疗在预防复发和降低出血风险方面是否有效?]","authors":"Luc Lanthier , Geneviève Le Templier , Alexandre Mutchmore , Marc-Émile Plourde , Michel Cauchon","doi":"10.1016/j.revmed.2025.06.011","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":54458,"journal":{"name":"Revue De Medecine Interne","volume":"46 9","pages":"Pages 566-567"},"PeriodicalIF":0.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chez les personnes atteintes d’un cancer actif et d’une maladie thromboembolique veineuse anticoagulée pendant au moins 6 mois, un traitement prolongé à dose réduite d’apixaban est-il efficace pour prévenir les récidives et diminuer le risque de saignement, comparativement à une dose complète ?\",\"authors\":\"Luc Lanthier , Geneviève Le Templier , Alexandre Mutchmore , Marc-Émile Plourde , Michel Cauchon\",\"doi\":\"10.1016/j.revmed.2025.06.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":54458,\"journal\":{\"name\":\"Revue De Medecine Interne\",\"volume\":\"46 9\",\"pages\":\"Pages 566-567\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue De Medecine Interne\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0248866325006599\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue De Medecine Interne","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0248866325006599","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Chez les personnes atteintes d’un cancer actif et d’une maladie thromboembolique veineuse anticoagulée pendant au moins 6 mois, un traitement prolongé à dose réduite d’apixaban est-il efficace pour prévenir les récidives et diminuer le risque de saignement, comparativement à une dose complète ?
期刊介绍:
Official journal of the SNFMI, La revue de medecine interne is indexed in the most prestigious databases. It is the most efficient French language journal available for internal medicine specialists who want to expand their knowledge and skills beyond their own discipline. It is also the main French language international medium for French research works. The journal publishes each month editorials, original articles, review articles, short communications, etc. These articles address the fundamental and innumerable facets of internal medicine, spanning all medical specialties. Manuscripts may be submitted in French or in English.
La revue de medecine interne also includes additional issues publishing the proceedings of the two annual French meetings of internal medicine (June and December), as well as thematic issues.